OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2024-03-29-accounts

ANNUAL REPORT FOR THE PERIOD ENDING MARCH 2024 ROBIN CANCER TRUST we save lives. ROBIN CANCER TRUST TAlklMG 301IOCKS SAVESLIVES

OUR VISION Our vision is to reach every young person in the UK with our life-saving cancer campaigns. OUR MISSION Our mission is to stop young adults dying from germ cell cancer. OUR HOPE Our hope is no other family has to go through what we did. OUR VALUES RESPECT: Not only forthe important work we undertake but also forthe people who support our mission. We believe in open. honest and empathetic communication between ourselves and to our community. CREATIVITY: We are a small team with a big vision- to drive the change we want to see in the world, we must innovate, disrupt and experiment. TRUST: We are accountable to each other & our beneficiaries. We are responsible for upholding these values and the quality of work we undertake- and we will do so with integrity at all times. REG. CHARITY NO. 1148999

OUR IMPACT EDUCATE: We educate young people to give them the best chance of surviving germ cell cancer. ENGAGE: We engage young people with humour to break the stigma of talking about germ cell cancer. EMPOIIER: We empower young people affected by germ cell cancer to thrive. OUR HISTORY Since 2012. we have reached tens of millions of people online, engaged with hundreds of thousands of people in the community. and delivered life-saving educational talks to over100.000 young adults in schools, colleges & businesses across the UK. Tho Robin Cancer Trust was founded in 2012 by the Freeman family following the untimely death of their son and brother. Robin Freeman. aged just 24. Robin inspires us to raise awareness, reduce embarrassment and save young lives through the early detection of germ cell cancers. BOARD OF TRUSTEES Mark Freeman, Founder& Interim Chair Craig Hargreaves, Vice Chair Kerry-Ann Jervis Scott, Treasurer Claire Pearce Sara Hawkins John Cass

MESSAGE FROM THE CHAIR & CEO The past year has once again highlighted the resilience, passion, and determination of everyone connected to The Robin Cancer Trust. In a landscape defined by economic challenges. the cost-of-living crisis, and ongoing pressures on the healthcare system. our commitment to the germ cell cancer community has remained steadfast. We hove continued to put our community and their needs at the forefront of everything we do- being led by our values, allowing lived-experience to drive our services. and ensuring we reach all audiences and communities with our lifsaving cancer campaigns. The past12 months have been transformative for our charity and our community. We began the year by delivering the Colchester Half-marathon. bringing together thousands of runners across our hometown and raising over £43,000 towards our awareness. education. and support prograrnme& In November, to celebrote Men's Health Month, we brought together 700 runners for our BIG BALLSY RUN challenge. raising over £ll.000. and much more awareness in the process! Our education and outreach efforts have also grown significantly. We delivered more lifsaving talks than ever before. reaching thousands of students. community groups, and workplaces. We've expanded our resource offerings, creating tailored content that makes conversations about testicular and ovarian cancer easier and more accessible. And we've continued to embrace innovative ways to meet people where they are- at festivals, freshers fairs, and pride celebrations- spreading our lifsaving message far and wide. None of this would be possible without the incredible people behind the scenes. To our dedicated staff team, and Board of Trustees, your expertise and passion are the driving forces behind everything we achieve- thank you for everything you do for our community. To our fundraisers, volunteers. ambassadors, and donors, you are the heart of this charity. Your tireless efforts, creativity, and generosity are what make our lifsaving work possible. As we look ahead to the next12-months. we are filled with excitement and optimism f or what we can accomplish together. From expanding our services. resources, and programmes- to reaching more people across the UK with our liftrsaving message. We can't wait to continue this journey with all of you. Thank you for standing with us every step of the way. MARK FREEMAN. FOUNDER & INTERIM CHAIR TOBY FREEMAN. FOUNDER & CEO

IIE SAVE LIVES ROBIN CANCER TRUST R¢>o6N CAN-CER rRUST*• , (dil TAlklNG BOIIOCkS SAVES LIVES f Ji)

TAIKING 30IIOIK SAVES IIVE5.. EDUCATE This year we continued to reach thousands of students with our liftrsaving educational talks by attending schools, colleges and universities across the region. We delivered our Cancer Education Programme both in-porson and virtually to make our information as accessible as possible. Our Freshers Fair program remains a huge success. with our attendance growing yearly- delivering our testicular and ovarian cancer awareness information to thousands of young people at a vital time in their lives. we continue to develop our relations with our student ambassadors. Evidence from delivery of our Cancer Education Programme demonstrates its effectiveness. For example. following delivery of 30 sessions across the South East with over 400 participants: • 9TA of participants reported feeling very confident in knowing the signs and symptoms oftesticularand ovariancancerslollowing ourtalL 'It was funny and Informative. l enjoyed the game true and that's ponts. Before I didn't know about testicular cancer. Now I know the signs and how to check myself" _ Student

TAlklNG 50IIOIKS SAVESLIVES ENGAGE Through our engaging awareness raising campaigns, we aim to break the stigma of talking about germ cell cancers. We work to raise awareness of the potential signs and symptoms and encourage people to contact their GP promptly to enable earlier diagnosis. We continuo to grow our nationally rocognised cancer awareness campaigns

TalkingBollocks and #NotOvaryacting- working with national partners to

reach as many young people as possible. These campaigns work to highlight the importance of early detection, promote awareness of the signs and symptoms, and tackle embarrassment experienced byyoung men and women which can prevent or delaythem in seeking treatment& • Wereached millions ofyoung adults online,and tens ofthousand of peoplein thecommunity.withouraward-winning #TalkingBollocks and #Notovaryacting campaigns °Amazing charity saving lives by creating awareness of such a rare form of cancer" _ Lynsday. Facebook

T41kl I'M NOT OYARYACTING EMPOWER The Thriver Program continues to grow nationally, enabling anyone in the UK to access free cancer support packs. We're incredibly grateful to our partners working on the front-line in healthcare- in organisations and hospÉtals- who support ourefforts to reach the germ cell community with our resources. Alongside this. wo have our dedicated Thriver resources on our website to help people navigate their journeys, and our blog series has allowed our community to share their stories. raw and uncut • This year, we provided Thriver packs to 51 people. helping support our communityduring the most difficulttimeoftheirlife. °Just want to say a huge thank you for the fabulous ThriverPack. It was an absolute joy to receive. Each helpful & thoughtful item will make such a difference os I face my Chemotheropy treatment and will help me deal with any side effects. The 'colouring book, is a huge hit, not only with me but with my friends and family tool I'll be colouring away at my future appointments - love the stotementsll . Thriver

L￿r 1071 EVENTS We've had another amazing yearof events- and we're so proud of every single one of our supporters who organised. entered. or fundraised for us! From half-marathon efforts, to thre*peak challenges, to walking pier- t<Trpier in their pants- our supporters have done it all! Our events offering continues to grow. allowing our supporters a widtr range of experiences- from walks, runs, treks, skydives and everything in- between! Our fantastic staff team ensures that everyone feels valued and supported. whatever challenge or event they take part in. •Thankyou toall our amazingfundraisers.donors. partners and supporters for helping us raise vital fundsfor germ cell cancer awareness, educatiory and support! °In all my years of volunteering & fundraising I have never been given a hand written thank you card at on event"_ Linda, Fundraiser& Volunteer

THE NEXT 12 MONTHS Our organisational goals for the next12-months are to increase the reach and impact of our life-saving cancer campaigns. and expand our education. awareness, and support programmes so that we can support as many people as possible across the UK. To achieve this, we will be focusing on four key areas: EDUCATION: The next steps in our Cancer Education Programme will be to expand our reach and staff base across the country, locating staff and cancer education at the heart of communities who need it most. AIIARENESS: We will continue working closely with partners to create diverse. inclusive and representative resources, to help us achieve our goal of'awareness for all'_ helping us reach communities and audiences all across the UK. SUPPORT: We will continue to advocate for, and empower, our community through ctrcreated resources to support those affected by germ cell cancer. We will be expanding our Thriver Pack offering by recruiting a dedicated Clinical Nurse Specialist to create, manage and support online germ cell cancer community forum, and putting lived-experience at the forefront of our support programmes. We are also very excited to be launching the Thrive Against Cancer podcast- giving a voice to the cancer community. We will be hosting open and honest conversations with people affected by cancer, their loved ones, health professionals, and the organisations and charities that support them. INCOME GENERATION: Providing liftrsaving services to the community requires us to diversify and grow our fundraising portfolio sustainably. Since acquiring the Colchester Half Marathon we have significantly increased the entries and income which we hope will continue to grow, along with our increased focus on Trusts & Foundations fundraising. We have also created several in-person and virtual events for our supporters to engage with.

THANK You! There are far too many people to mention specifically, but we want to take this opportunity to thank every single donor. fundraiser. volunteer, business, organisation, and partner who have supported The Robin Cancer Trust over the past12-months! Thanks to you we are able to continue to support the UK'S germ cell cancer community- and to deliver liftrsaving cancer awareness. education, and support to young adults all across the UK. In short: YOU ARE AMAZEBALLS! ROBIN CANCER TRUST

CONTACT US E'D LOVE TO HEAR FROM YOU! ROBIN CANCER TRUST we save lives. The Robin Cancer Trust, 29 Queens Road. Wivenhoe. Essex. C07 9JJ www.therobincancertrust.org info@therobincancertrust.org @rctcharity #TalkingBollocks #Notovaryacting

Charity registration number 1148999

THE ROBIN CANCER TRUST

ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2024

THE ROBIN CANCER TRUST

LEGAL AND ADMINISTRATIVE INFORMATION

Trustees Mr M Freeman (Founder & Interim
Chair)
Mr C Hargreaves (Chair)
Ms K Jervis-Scott (Treasurer)
Mrs C Pearce
Mrs S Hawkins
Mr J Cass
Ms N Cedeno (Appointed 14 May 2024)
Chief Executive Officer Mr T Freeman
Charity number 1148999
Principal address 29 Queens Road
Wivenhoe
Colchester
CO7 9JJ
Independent examiner Daniel Insley BA ACA
c/o The Old Exchange
64 West Stockwell Street
Colchester
Essex
CO1 1HE
Bankers Metro Bank PLC
One Southampton Row
London
WC1B 5HA

THE ROBIN CANCER TRUST

CONTENTS

Page
Trustees' report 1 - 2
Independent examiner's report 3
Statement of financial activities 4
Balance sheet 5
Notes to the financial statements 6 - 15

THE ROBIN CANCER TRUST

TRUSTEES' REPORT

FOR THE PERIOD ENDED 31 MARCH 2024

The trustees present their annual report and financial statements for the period ended 31 March 2024.

The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the charity's governing document, the Charities Act 2011 and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019).

Objectives and activities

Our Vision

To stop young adults dying from germ cell cancer.

Our Mission

To reach every young person in the UK with our life-saving cancer campaigns.

Our Hope

No other family has to go through what we did.

Our Impact

We educate young people to give them the best chance of surviving germ cell cancer. We engage young people with humour to break the stigma of talking about germ cell cancer. We empower young people effected by germ cell cancer to thrive.

Public benefit

The trustees have paid due regard to guidance issued by the Charity Commission in deciding what activities the charity should undertake.

Achievements and performance

Significant activities and achievements against objectives

Over the course of the year we undertook countless activities to raise awareness of germ cell cancer and raise much needed funds with the help of our supporters, volunteers and team members.

Education

Alongside our in-person educational talks, we have developed a library of free digital resources for educational establishments to use for their students - allowing us to reach a national audience with our life-saving message.

Awareness

Our mantra is "awareness for all" because we believe everyone deserves access to our life-saving cancer campaigns.

Over the past 12 months we have created, curated and collaborated with partners so that we could reach as many people and communities as possible with our #TalkingBollocks and #NotOvaryActing cancer campaigns

Support

Our "Thriver" cancer support packs have continued to help those going through the hardest time of their lives.

We have continued to work alongside our community to empower those people affected by germ cell cancer to thrive. Listening to the experience of others to better shape our services and programmes so we can better serve our beneficiaries and have a positive impact on their lives.

THE ROBIN CANCER TRUST

TRUSTEES' REPORT (CONTINUED) FOR THE PERIOD ENDED 31 MARCH 2024

Financial review

At the 31 March 2024 the total reserves of the Charity were £105,938 (28 February 2023: £71,908), of which £74,852 (28 February 2023: £53,667) were unrestricted funds, and £31,086 (28 February 2023: £18,241) were restricted funds.

Reserves policy

It is the policy of the charity that unrestricted funds which have not been designated for a specific use should be maintained at a level equivalent to between three and six months expenditure. The trustees consider that reserves at this level will ensure that, in the event of a significant drop in funding, they will be able to continue the charity’s current activities while consideration is given to ways in which additional funds may be raised. This level of reserves has been maintained throughout the period.

Structure, governance and management

The trustees who served during the period and up to the date of signature of the financial statements were: Mr M Freeman (Founder & Interim Chair)

Mr C Hargreaves (Chair) Ms K Jervis-Scott (Treasurer) Mrs C Pearce Mrs S Hawkins Mr J Cass Mr J Clark (Resigned 19 July 2023) Ms N Cedeno (Appointed 14 May 2024)

Recruitment and appointment of trustees

The management of the Charity is the responsibility of the Trustees who are elected under the terms of the Trust Deed.

The Board of Trustees has the power to appoint and remove trustees on a majority basis, with the Chair of Trustees having the casting vote where necessary.

Organisational structure

The Board of Trustees have oversight management of the Charity, delegating the operational management to the CEO who is supported by a Community Manager, and marketing, social media, and communications staff. Financial operations are managed by the Treasurer.

The trustees' report was approved by the Board of Trustees.

Mr C Hargreaves (Chair)

24 January 2025

THE ROBIN CANCER TRUST

INDEPENDENT EXAMINER'S REPORT

TO THE TRUSTEES OF THE ROBIN CANCER TRUST

I report to the trustees on my examination of the financial statements of The Robin Cancer Trust (the charity) for the period ended 31 March 2024.

Responsibilities and basis of report

As the trustees of the charity you are responsible for the preparation of the financial statements in accordance with the requirements of the Charities Act 2011 (the 2011 Act).

I report in respect of my examination of the charity’s financial statements carried out under section 145 of the 2011 Act. In carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.

Independent examiner's statement

Since the charity’s gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of The Institute of Chartered Accountants in England and Wales, which is one of the listed bodies.

Your attention is drawn to the fact that the charity has prepared financial statements in accordance with Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) in preference to the Accounting and Reporting by Charities: Statement of Recommended Practice issued on 1 April 2005 which is referred to in the extant regulations but has now been withdrawn.

I understand that this has been done in order for financial statements to provide a true and fair view in accordance with Generally Accepted Accounting Practice effective for reporting periods beginning on or after 1 January 2015.

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.

Daniel Insley BA ACA

c/o The Old Exchange 64 West Stockwell Street Colchester Essex CO1 1HE

Dated: 24 January 2025

THE ROBIN CANCER TRUST

STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE PERIOD ENDED 31 MARCH 2024

Unrestricted
Restricted
funds
funds
2024
2024
Notes
£
£
Income from:
Donations and legacies
3
315,419
57,142
Charitable activities
4
-
-
Investments
5
762
-
Total income
316,181
57,142
Expenditure on:
Raising funds
6
15,427
-
Charitable activities
7
279,569
44,297
Total expenditure
294,996
44,297
Net income and movement in
funds
21,185
12,845
Reconciliation of funds:
Fund balances at 1 March 2023
53,667
18,241
Fund balances at 31 March
2024
74,852
31,086
Total
Unrestricted
Restricted
funds
funds
2024
2023
2023
£
£
£
372,561
119,386
21,241
-
800
-
762
138
-
373,323
120,324
21,241
15,427
10,441
-
323,866
111,188
3,000
339,293
121,629
3,000
34,030
(1,305)
18,241
71,908
54,972
-
105,938
53,667
18,241
Total
2023
£
140,627
800
138
141,565
10,441
114,188
124,629
16,936
54,972
71,908

The statement of financial activities includes all gains and losses recognised in the period. All income and expenditure derive from continuing activities.

THE ROBIN CANCER TRUST

BALANCE SHEET

AS AT 31 MARCH 2024

Notes
Fixed assets
Tangible assets
13
Current assets
Debtors
14
Cash at bank and in hand
Creditors: amounts falling due within one
year
15
Net current assets
Total assets less current liabilities
The funds of the charity
Restricted income funds
17
Unrestricted funds
18
2024
£
17,303
149,557
166,860
(62,021)
£
1,099
104,839
105,938
31,086
74,852
105,938
2023
£
11,816
106,342
118,158
(46,792)
£
542
71,366
71,908
18,241
53,667
71,908

The financial statements were approved by the trustees on 24 January 2025

Mr C Hargreaves (Chair)

NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2024

THE ROBIN CANCER TRUST

1 Accounting policies

Charity information

The Robin Cancer Trust is a charity, registered with the Charity Commission for England and Wales and is regulated by the Trust Deed dated 14 September 2012.

1.1 Accounting convention

The financial statements have been prepared in accordance with the charity's [governing document], the Charities Act 2011, FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019). The charity is a Public Benefit Entity as defined by FRS 102.

The charity has taken advantage of the provisions in the SORP for charities not to prepare a Statement of Cash Flows.

The financial statements have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a true and fair view. This departure has involved following the Statement of Recommended Practice for charities applying FRS 102 rather than the version of the Statement of Recommended Practice which is referred to in the Regulations but which has since been withdrawn.

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2 Going concern

At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3 Charitable funds

Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives.

Restricted funds are subject to specific conditions by donors or grantors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements.

1.4 Income

Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.

Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.

Legacies are recognised on receipt or otherwise if the charity has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a contingent asset.

THE ROBIN CANCER TRUST

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE PERIOD ENDED 31 MARCH 2024

1 Accounting policies

(Continued)

1.5 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement, and the amount of the obligation can be measured reliably.

Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges are allocated on the portion of the asset’s use.

1.6 Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings 3 Year Straight Line Computers 3 Year Straight Line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities.

1.7 Impairment of fixed assets

At each reporting end date, the charity reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

1.8 Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

THE ROBIN CANCER TRUST

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE PERIOD ENDED 31 MARCH 2024

1 Accounting policies

(Continued)

1.9 Financial instruments

The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial instruments are initially recognised at transaction value and subsequently measured at amortised cost. Financial assets comprise cash at bank and in hand, together with trade and other debtors. A specific provision is made for debts for which recoverability is in doubt. Cash at bank and in hand is defined as all cash held in instant access bank accounts and used as working capital. Financial liabilities held at amortised cost comprise all creditors except social security and other taxes, deferred income and provisions.

1.10 Employee benefits

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the charity is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.11 Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2 Critical accounting estimates and judgements

In the application of the charity’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

THE ROBIN CANCER TRUST

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE PERIOD ENDED 31 MARCH 2024

3
Donations and legacies
Unrestricted
Restricted
funds
funds
2024
2024
£
£
Donations and gifts
268,661
57,142
Other Grant Income
46,082
-
Gift Aid
676
-
315,419
57,142
Total
Unrestricted
Restricted
funds
funds
2024
2023
2023
£
£
£
325,803
119,366
-
46,082
-
21,241
676
20
-
372,561
119,386
21,241
Total
2023
£
119,366
21,241
20
140,627

4 Income from charitable activities

Unrestricted Unrestricted
funds funds
2024 2023
£ £
Charitable Activities
Sale of goods - 800
Income from investments
Unrestricted Unrestricted
funds funds
2024 2023
£ £
Interest receivable 762 138

THE ROBIN CANCER TRUST

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE PERIOD ENDED 31 MARCH 2024

6 Raising funds

**Unrestricted ** Unrestricted
funds funds
2024 2023
£ £
Fundraising and publicity
Seeking donations, grants and legacies 7,005 3,598
Advertising 8,422 6,843
Fundraising and publicity 15,427 10,441
15,427 10,441
Expenditure on charitable activities
Charitable Charitable
Activities Activities
2024 2023
£ £
Direct costs
Staff costs 136,240 83,783
Depreciation and impairment 450 192
Staff and Other Overheads 140,967 6,777
277,657 90,752
Share of support and governance costs (see note 8)
Support 23,859 13,097
Governance 22,350 10,339
323,866 114,188
Analysis by fund
Unrestricted funds 279,569 111,188
Restricted funds 44,297 3,000
323,866 114,188

7 Expenditure on charitable activities

THE ROBIN CANCER TRUST

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE PERIOD ENDED 31 MARCH 2024

8
Support costs allocated to activities
Insurance
It Software, Telephone & Consumables
Office Equipment & Consumables
Rent
Repairs
Postage, Freight & Courier
General Expenses
Travel
Charitable Activities
Bank Charges
Governance costs
Analysed between:
Charitable Activities
9
Net movement in funds
The net movement in funds is stated after charging/(crediting):
Fees payable for the independent examination of the charity's financial
statements
Depreciation of owned tangible fixed assets
2024
£
271
1,927
6,502
2,229
510
817
625
2,667
-
8,311
22,350
46,209
46,209
2024
£
1,764
450
2023
£
249
2,708
4,687
-
-
324
2,349
915
435
1,430
10,339
23,436
23,436
2023
£
1,680
192

10 Trustees

None of the trustees (or any persons connected with them) received any remuneration during the period, but 1 of them was reimbursed a total of £76 travelling expenses (2023- none were reimbursed).

11 Employees

The average monthly number of employees during the period was:

2024 2023
Number Number
4 3

THE ROBIN CANCER TRUST

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE PERIOD ENDED 31 MARCH 2024

11
Employees
Employment costs
Wages and salaries
Social security costs
Other pension costs
(Continued)
2024
2023
£
£
127,731
79,445
5,723
2,513
2,786
1,825
136,240
83,783
(Continued)
2024
2023
£
£
127,731
79,445
5,723
2,513
2,786
1,825
136,240
83,783
83,783

There were no employees whose annual remuneration was more than £60,000.

12 Taxation

The charity is exempt from tax on income and gains falling within section 505 of the Taxes Act 1988 or section 252 of the Taxation of Chargeable Gains Act 1992 to the extent that these are applied to its charitable objects.

13 Tangible fixed assets

Fixtures and
fittings
Computers
£
£
Cost
At 1 March 2023
179
555
Additions
186
821
At 31 March 2024
365
1,376
Depreciation and impairment
At 1 March 2023
36
156
Depreciation charged in the period
100
350
At 31 March 2024
136
506
Carrying amount
At 31 March 2024
229
870
At 28 February 2023
143
399
Total
£
734
1,007
1,741
192
450
642
1,099
542

THE ROBIN CANCER TRUST

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE PERIOD ENDED 31 MARCH 2024

14
Debtors
Amounts falling due within one year:
Trade debtors
Other debtors
Prepayments and accrued income
15
Creditors: amounts falling due within one year
Other taxation and social security
Trade creditors
Other creditors
Accruals and deferred income
16
Retirement benefit schemes
Defined contribution schemes
Charge to profit or loss in respect of defined contribution schemes
2024
£
5,000
12,303
-
17,303
2024
£
2,490
50,800
5,203
3,528
62,021
2024
£
2,786
2023
£
-
9,342
2,474
11,816
2023
£
-
-
44,729
2,063
46,792
2023
£
1,825

The charity operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the charity in an independently administered fund.

17 Restricted funds

The restricted funds of the charity comprise the unexpended balances of donations and grants held on trust subject to specific conditions by donors as to how they may be used.

At 1 March Incoming Resources At 31 March
2023 resources expended 2024
£ £ £ £
18,241 57,142 (44,297) 31,086

THE ROBIN CANCER TRUST

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE PERIOD ENDED 31 MARCH 2024

17 Restricted funds (Continued)
Previous year: At 1 March Incoming Resources
At
28 February
2022 resources expended 2023
£ £ £ £
- 21,241 (3,000) 18,241

18 Unrestricted funds

The unrestricted funds of the charity comprise the unexpended balances of donations and grants which are not subject to specific conditions by donors and grantors as to how they may be used. These include designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes.

At 1 March At 1 March Incoming Resources At 31 March At 31 March
2023 resources expended 2024
£ £ £ £
General funds 53,667 316,181 (294,996) 74,852
Previous year: At 1 March Incoming Resources
At
28 February
2022 resources expended 2023
£ £ £ £
General funds 54,972 120,324 (121,629) 53,667
Analysis of net assets between funds
Unrestricted Restricted Total
funds funds
2024 2024 2024
£ £ £
At 31 March 2024:
Tangible assets 1,099 - 1,099
Current assets/(liabilities) 73,753 31,086 104,839
74,852 31,086 105,938

19 Analysis of net assets between funds

THE ROBIN CANCER TRUST

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE PERIOD ENDED 31 MARCH 2024

19 Analysis of net assets between funds (Continued)
Unrestricted Restricted Total
funds funds
2023 2023 2023
£ £ £
At 28 February 2023:
Tangible assets 542 - 542
Current assets/(liabilities) 53,125 18,241 71,366
53,667 18,241 71,908

20 Related party transactions

There were no disclosable related party transactions during the period (2023 - none).